Array Biopharma, Inc. (ARRY) Tops Q2 EPS by 4c
Tweet Send to a FriendGet Alerts ARRY Hot Sheet
Price: $5.64 -2.76%
Financial Fact:
Total other income (expenses), net: -2.82M
Today's EPS Names:
BOSC, GASS, AAP, More
Financial Fact:
Total other income (expenses), net: -2.82M
Today's EPS Names:
BOSC, GASS, AAP, More
Trade ARRY Now!
Array Biopharma, Inc. (NASDAQ: ARRY) reported Q2 EPS of ($0.10), $0.04 better than the analyst estimate of ($0.14). Revenue for the quarter came in at $18.4 million versus the consensus estimate of $16.52 million.
For earnings history and earnings-related data on Array Biopharma, Inc. (ARRY) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For earnings history and earnings-related data on Array Biopharma, Inc. (ARRY) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Hewlett-Packard Company (HPQ) Tops Q2 EPS by 6c as Sales Slide 10%
- UPDATE: 8x8 Inc. (EGHT) Misses Q4 EPS by 1c
- Kirkland's, Inc. (KIRK) Tops Q1 EPS by 5c; Guides FY13 EPS
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
